Asthma and Chronic Obstructive Pulmonary Disease

Asthma and chronic obstructive pulmonary disease (COPD) are both highly prevalent diseases worldwide. This issue of Clinics in Chest Medicine discusses different aspects of COPD, but in addition, the present article on overlap and differential signs and symptoms with asthma has been included. This is appropriate because it is often difficult to differentiate asthma from COPD, particularly at older ages. At that time in life, patients with asthma may have developed persistent airway obstruction, a characteristic that is a prerequisite for diagnosis of COPD according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria. This feature would not be a problem if asthma and COPD had the same clinical prognosis and response to pharmacologic treatment, and required similar management of the disease in clinical practice. However, this is often not the case. Asthma and COPD have been defined over the years in many different ways, and the heterogeneity in definitions in the literature contributes to the difficulty of evaluating evidence about the extent to which they overlap. The problem is confounded by the necessary reliance in many epidemiologic studies on self-reported diagnosis of asthma and COPD, and because, in clinical practice, these diagnoses are often assigned without lung function testing having been performed.

[1]  M. R. Siddiqui,et al.  Global Initiative for Chronic Obstructive Lung Disease (GOLD) , 2017 .

[2]  D. Postma,et al.  Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. , 2013, The Journal of allergy and clinical immunology.

[3]  D. Postma,et al.  Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study , 2013, Respiratory Research.

[4]  D. Postma,et al.  Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma , 2013, Allergy.

[5]  E. R. Sutherland,et al.  A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. , 2012, American journal of respiratory and critical care medicine.

[6]  J. Hogg,et al.  Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[7]  David C. Nickle,et al.  Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma , 2012, PLoS genetics.

[8]  D. Sin,et al.  Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis , 2012, International journal of chronic obstructive pulmonary disease.

[9]  Y. Bossé,et al.  Updates on the COPD gene list , 2012, International journal of chronic obstructive pulmonary disease.

[10]  P. Berger,et al.  Airway smooth muscle in asthma: just a target for bronchodilation? , 2012, Clinics in chest medicine.

[11]  J. Soriano,et al.  Consensus document on the overlap phenotype COPD-asthma in COPD. , 2012, Archivos de bronconeumologia.

[12]  M. Saetta,et al.  Pathophysiology of the Small Airways in Chronic Obstructive Pulmonary Disease , 2012, Respiration.

[13]  Christopher E Brightling,et al.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.

[14]  Yusuke Nakamura,et al.  Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene , 2012, PLoS genetics.

[15]  L. Edwards,et al.  Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease , 2012, Thorax.

[16]  D. Postma,et al.  Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD , 2012, European Respiratory Journal.

[17]  R. Hancox,et al.  Asthma phenotypes: Consistency of classification using induced sputum , 2012, Respirology.

[18]  Kathleen M. Akgün,et al.  Epidemiology and management of common pulmonary diseases in older persons. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  B. Celli,et al.  Bronchodilator reversibility in COPD. , 2011, Chest.

[20]  Joyce D. Schroeder,et al.  The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.

[21]  D. Postma,et al.  I have taken my umbrella, so of course it does not rain , 2011, Thorax.

[22]  D. Postma,et al.  Asthma and chronic obstructive pulmonary disease: common genes, common environments? , 2011, American journal of respiratory and critical care medicine.

[23]  C. Salome,et al.  Predictors of airway hyperresponsiveness differ between old and young patients with asthma. , 2011, Chest.

[24]  Bram van Ginneken,et al.  CT-quantified emphysema in male heavy smokers: association with lung function decline , 2011, Thorax.

[25]  T. Haahtela,et al.  Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[26]  D. Postma,et al.  Small airway disease in asthma and COPD: clinical implications. , 2011, Chest.

[27]  D. Postma,et al.  Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). , 2010, Respiratory medicine.

[28]  L. Fabbri,et al.  Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. , 2010, The Journal of allergy and clinical immunology.

[29]  N. Pride,et al.  Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease , 2010, Thorax.

[30]  D. Postma,et al.  Airway epithelial changes in smokers but not in ex-smokers with asthma. , 2009, American journal of respiratory and critical care medicine.

[31]  D. Postma,et al.  Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. , 2009, Annals of internal medicine.

[32]  T. Welte,et al.  Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[33]  P. Gibson,et al.  The overlap syndrome of asthma and COPD: what are its features and how important is it? , 2009, Thorax.

[34]  C. Kroegel Global Initiative for Asthma (GINA) guidelines: 15 years of application , 2009, Expert review of clinical immunology.

[35]  D. Postma,et al.  Maternal smoking during pregnancy induces airway remodelling in mice offspring , 2009, European Respiratory Journal.

[36]  M. Weatherall,et al.  Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.

[37]  D. Postma,et al.  Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation , 2009, International journal of chronic obstructive pulmonary disease.

[38]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[39]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[40]  Anand A. Dalal,et al.  Burden of concomitant asthma and COPD in a Medicaid population. , 2008, Chest.

[41]  M. Decramer,et al.  Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.

[42]  M. Dolhnikoff,et al.  Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease , 2008, Current opinion in pulmonary medicine.

[43]  I. Pavord,et al.  Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. , 2007, Chest.

[44]  B. Caldwell,et al.  External validity of randomized controlled trials in COPD. , 2007, Respiratory medicine.

[45]  I. Pavord,et al.  Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial , 2007, European Respiratory Journal.

[46]  Sylvia Verbanck,et al.  Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation , 2007, Thorax.

[47]  Richard Beasley,et al.  External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? , 2006, Thorax.

[48]  K. Rabe,et al.  Differential distribution of inflammatory cells in large and small airways in smokers , 2006, Journal of Clinical Pathology.

[49]  D. Postma,et al.  Predictors of COPD symptoms: does the sex of the patient matter? , 2006, European Respiratory Journal.

[50]  C. Brightling,et al.  Eosinophilic airway inflammation in COPD , 2006, International journal of chronic obstructive pulmonary disease.

[51]  D. Price,et al.  International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.

[52]  D. Postma,et al.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.

[53]  N. Thomson,et al.  Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma , 2005, Thorax.

[54]  I. Pavord,et al.  Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease , 2005, Thorax.

[55]  S. Guerra Overlap of asthma and chronic obstructive pulmonary disease , 2005, Current opinion in pulmonary medicine.

[56]  L. Grinberg,et al.  Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. , 2004, American journal of respiratory and critical care medicine.

[57]  Dirkje S Postma,et al.  Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. , 2004, Chest.

[58]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[59]  D. Rogers Airway mucus hypersecretion in asthma: an undervalued pathology? , 2004, Current opinion in pharmacology.

[60]  Joan B Soriano,et al.  The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.

[61]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[62]  M. Paiva,et al.  Nonreversible conductive airway ventilation heterogeneity in mild asthma. , 2003, Journal of applied physiology.

[63]  D. Postma,et al.  Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.

[64]  L. Corbetta,et al.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[65]  A. Buist,et al.  Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes , 2003, European Respiratory Journal.

[66]  D. Mannino,et al.  Characteristics of adults dying with COPD. , 2002, Chest.

[67]  L. Palmer,et al.  Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. , 2002, American journal of respiratory and critical care medicine.

[68]  H. Kauffman,et al.  Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[69]  L. Fabbri,et al.  Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[70]  S. Weiss,et al.  Atopy as a risk factor for chronic obstructive pulmonary disease: epidemiological evidence. , 2000, American journal of respiratory and critical care medicine.

[71]  C. Jenkins,et al.  Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.

[72]  D. Postma,et al.  Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.

[73]  M Paiva,et al.  Evidence of acinar airway involvement in asthma. , 1999, American journal of respiratory and critical care medicine.

[74]  Dirkje S Postma,et al.  Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.

[75]  D. Postma,et al.  Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[76]  M. Noppen,et al.  Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. , 1998, American journal of respiratory and critical care medicine.

[77]  F. Dekker,et al.  Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study , 1998, BMJ.

[78]  J. Bousquet,et al.  Corticosteroid reversibility in COPD is related to features of asthma. , 1997, American journal of respiratory and critical care medicine.

[79]  J. Vestbo,et al.  Chronic mucus hypersecretion in COPD and death from pulmonary infection. , 1995, The European respiratory journal.

[80]  M. Cosio,et al.  Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. , 1995, American journal of respiratory and critical care medicine.

[81]  D. Postma,et al.  Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group. , 1995, American journal of respiratory and critical care medicine.

[82]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[83]  A. James,et al.  The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.

[84]  D. Postma,et al.  A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.

[85]  P. Paré,et al.  A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[86]  E. Bleecker,et al.  The Lung Health Study: Airway Responsiveness to Inhaled Methacholine in Smokers with Mild to Moderate Airflow Limitation , 1992 .

[87]  S. Sahn Corticosteroids in chronic bronchitis and pulmonary emphysema. , 1978, Chest.

[88]  T. Kennedy,et al.  Effect of aging alone on mechanical properties of the normal adult human lung. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.

[89]  D. Niewoehner,et al.  Pathologic changes in the peripheral airways of young cigarette smokers. , 1974, The New England journal of medicine.

[90]  H. Magnussen,et al.  Improvements with tiotropium in COPD patients with concomitant asthma. , 2008, Respiratory medicine.

[91]  A. B. Kay,et al.  Overview of 'allergy and allergic diseases: with a view to the future'. , 2000, British medical bulletin.

[92]  A. James,et al.  The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. , 2000, American journal of respiratory and critical care medicine.

[93]  G. O'Connor,et al.  The relation of airways responsiveness and atopy to the development of chronic obstructive lung disease. , 1988, Epidemiologic reviews.